Elizabeth M. Greetham
Président chez The Art Room Ltd.
Profil
Elizabeth M.
Greetham is currently the Chairman of The Art Room Ltd.
and a Trustee at Place2Be.
In the past, she served as the President & CEO of ACCL Financial Consultants Ltd.
from 2003 to 2007 and as the Chairman & CEO of Drugabuse Sciences, Inc. from 1998 to 2004.
She also held director positions at Ligand Pharmaceuticals, Inc., Guilford Pharmaceuticals, Inc., KP Pharmaceuticals LLC, and Nventa Biopharmaceuticals Corp.
Additionally, she worked as a Portfolio Manager at Robeco Weiss, Peck & Greer Investments and Weiss, Peck & Greer LLC.
Ms. Greetham graduated from The University of Edinburgh in 1971.
Postes actifs de Elizabeth M. Greetham
| Sociétés | Poste | Début |
|---|---|---|
Place2Be
 Place2Be Investment Trusts/Mutual FundsMiscellaneous Place2Be is a non-profit organization which provides emotional and therapeutic services in primary and secondary schools. It helps pupils to cope with often social issues including bullying, bereavement, domestic violence, family breakdown, neglect, and trauma. The company was founded by Dame Benita Refson in 1994 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | - |
The Art Room Ltd.
 The Art Room Ltd. Services to the Health IndustryHealth Services The Art Room Ltd. provides art training for primary and secondary schools. The company was founded by Juli Beattie and is headquartered in Oxford, the United Kingdom. | Président | - |
Anciens postes connus de Elizabeth M. Greetham
| Sociétés | Poste | Fin |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Directeur/Membre du Conseil | 29/07/2008 |
| ACCL Financial Consultants Ltd. | President | 31/12/2007 |
Guilford Pharmaceuticals, Inc.
 Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Directeur/Membre du Conseil | 03/10/2005 |
| Drugabuse Sciences, Inc. | Président | 01/01/2004 |
| Weiss, Peck & Greer LLC | Corporate Officer/Principal | - |
Formation de Elizabeth M. Greetham
| The University of Edinburgh | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| Entreprise privées | 9 |
|---|---|
Robeco Weiss, Peck & Greer Investments
 Robeco Weiss, Peck & Greer Investments Investment ManagersFinance A subsidiary of Robeco Investment Management, Robeco Weiss, Peck & Greer Investments is an investment adviser headquartered in New York City with an additional office in Menlo Park, California. The firm was founded in 1970. Their ultimate parent is Cooperative Centrale Raiffeisen Boerenleenbank. | Finance |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
KP Pharmaceuticals LLC
 KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology KP Pharmaceuticals LLC is a pharmaceuticals company which develops, manufactures, markets and sells branded prescription pharmaceutical products. The company was founded by John M. Gregory, Randal J. Kirk, Joseph R. Gregory, Jefferson J. Gregory and James E. Gregory in 1993 and is is headquartered in Bristol, TN. | Health Technology |
Nventa Biopharmaceuticals Corp.
 Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada. | Health Technology |
| ACCL Financial Consultants Ltd. | |
| Drugabuse Sciences, Inc. | |
| Weiss, Peck & Greer LLC | Finance |
Place2Be
Place2Be Investment Trusts/Mutual FundsMiscellaneous Place2Be is a non-profit organization which provides emotional and therapeutic services in primary and secondary schools. It helps pupils to cope with often social issues including bullying, bereavement, domestic violence, family breakdown, neglect, and trauma. The company was founded by Dame Benita Refson in 1994 and is headquartered in London, the United Kingdom. | Miscellaneous |
The Art Room Ltd.
The Art Room Ltd. Services to the Health IndustryHealth Services The Art Room Ltd. provides art training for primary and secondary schools. The company was founded by Juli Beattie and is headquartered in Oxford, the United Kingdom. | Health Services |
